Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siponimod in Mild Alzheimer's Disease
NCT06639282Phase 2Recruiting
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- Aug 2025
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of siponimod in Alzheimer's disease (AD), sponsored by St. Joseph's Hospital and Medical Center. Started Aug 2025; status: recruiting.
02
Drugs
siponimod
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06639282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06639282.